Waltz Health and Fresenius Kabi are moving to offer three biosimilars through a direct-to-payer model, bypassing traditional wholesaler and pharmacy benefit manager rebate channels entirely. The partnership represents a significant shift in
Elastic N.V. (NYSE: ESTC), the search-powered data analytics company, saw its stock surge 23.1% after reporting second-quarter results that exceeded revenue expectations for the period. The sharp single-session gain reflects significant investor
More
One City broker has identified a FTSE 250 stock it believes could deliver gains of as much as 103% from its current trading price. The recommendation has drawn attention from investors seeking
More
Cytokinetics, Incorporated (Nasdaq: CYTK) has presented a broad package of new clinical data for MYQORZO at the European Society of Cardiology Heart Failure 2026 Congress. The presentations reinforced the clinical profile of
More
The Centers for Medicare and Medicaid Services has increasingly positioned Medicare enrollment requirements as a key tool for maintaining program integrity across the healthcare system. Medicare enrollment has traditionally been viewed as
More
The FTSE 100 opened firmly higher on Friday, recovering around 60% of Thursday’s decline as mining and financial stocks drove a broad blue-chip advance across London markets. London’s leading index gained 50.99
More
Dividend investing continues to attract significant interest from income-focused investors seeking reliable returns in an uncertain economic environment. Ultra-high-yield dividend stocks often carry a reputation for risk, but selective picks can offer
More
Ronaldo has shared fresh photographs of his extraordinary car collection on Instagram, captioning the post simply “my toys” for his millions of followers. The Al-Nassr striker, aged 41, has previously admitted to
More
Roivant Sciences (ROIV) and its partner Priovant Therapeutics have secured FDA approval for Lisraya, a first-in-class oral treatment for the rare autoimmune disease dermatomyositis. The U.S. Food and Drug Administration approved Lisraya,
More
Wells Fargo’s Legal Specialty Group has released its six-month 2026 survey, and the headline numbers show Biglaw enjoying one of its strongest years on record. Revenue across the Am Law 200 climbed
More
Colman’s Mustard is being put up for sale by its parent company Unilever as part of a sweeping merger between the FTSE 100 giant’s food division and US spice giant McCormick. Bankers
More